Refresh

Bliss GVS Pharma Ltd. - Research Center

506197 BLISSGVS Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

598.34 636.36 465.51 441.95 426.59
Expenses

Material consumed

314.90 343.94 253.30 236.72 225.15

Manufacturing expenses

5.80 7.09 6.99 4.70 3.57

Personnel expenses

72.54 65.06 58.61 44.02 33.85

Selling expenses

0.50 0.14 0.17 0.56 0.38

Adminstrative expenses

114.45 110.92 54.98 55.78 70.55

Expenses capitalised

- - - - -

Cost of sales

508.18 527.16 374.05 341.78 333.49

Operating profit

90.16 109.20 91.46 100.17 93.10

Other recurring income

50.77 32.63 17.68 37.00 35.81

Adjusted PBDIT

140.92 141.83 109.14 137.17 128.91

Financial expenses

10.06 4.32 4.19 6.62 3.15

Depreciation

15.17 13.85 13.76 8.83 5.75

Other write offs

- - - - -

Adjusted PBT

115.69 123.66 91.19 121.71 120.01

Tax charges

30.21 33.74 23.69 29.38 45.58

Adjusted PAT

85.48 89.92 67.50 92.33 74.43

Non recurring items

-0.67 3.05 0.52 -0.26 -

Other non cash adjustments

- - - - -

Reported net profit

84.81 92.97 68.02 92.08 74.43

Earnigs before appropriation

850.15 769.19 681.38 625.77 546.23

Equity dividend

5.19 5.18 5.16 12.41 8.22

Preference dividend

- - - - -

Dividend tax

- - - - 2.09

Retained earnings

844.96 764.02 676.22 613.36 535.92
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com